Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Thompson

Showing results (141-150 of 253) with videos related to

Pageof 26
Sort By:
Toxicology and Applied Pharmacology|July 1, 1973
Chronic oral toxicity of cannabinoids in ratsG R Thompson, M M Mason, H Rosenkrantz, et al.
Clinical Endocrinology|September 1, 1992
Phaeochromocytomas as a cause of hypotensionM A Baxter, P Hunter, G R Thompson, et al.
Arteriosclerosis (Dallas, Tex.)|January 1, 1989
Plasmapheresis in familial hypercholesterolemiaG R Thompson, M Barbir, K Okabayashi, et al.
Circulation|October 15, 1995
Lipoprotein(a) may have contrasting effects on different aspects of atherosclerotic coronary diseaseR Narang, S Niththyananthan, C Nonis, et al.
Archives of Physical Medicine and Rehabilitation|May 1, 1974
Arthrography in the diagnosis of shoulder pain and immobilityJ J Weiss, G R Thompson, V Doust, et al.
Lancet (London, England)|November 4, 1989
Plasma mevalonate response in lovastatin-related myopathyV M Maher, A Pappu, D R Illingworth, et al.
Clinical Rheumatology|December 1, 1982
X-linked spondyloepiphyseal dysplasia tarda: mucopolysaccharide excretion studiesG R Thompson, D E Thompson, D S McCann, et al.
Archives of Internal Medicine|November 1, 1978
Familial occurrence of hyperuricemia, gout, and medullary cystic diseaseG R Thompson, J J Weiss, R T Goldman, et al.
Atherosclerosis|November 1, 1995
Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity?V M Maher, J J Gallagher, G R Thompson, et al.
Michigan Medicine|September 1, 1970
A controlled study of niacinamide therapyG R Thompson, I F Duff, E F Hvidberg, et al.
Pageof 26

Showing results (141-150 of 253) with videos related to

Sort By:
Pageof 26
Toxicology and Applied Pharmacology|July 1, 1973
Chronic oral toxicity of cannabinoids in ratsG R Thompson, M M Mason, H Rosenkrantz, et al.
Clinical Endocrinology|September 1, 1992
Phaeochromocytomas as a cause of hypotensionM A Baxter, P Hunter, G R Thompson, et al.
Arteriosclerosis (Dallas, Tex.)|January 1, 1989
Plasmapheresis in familial hypercholesterolemiaG R Thompson, M Barbir, K Okabayashi, et al.
Circulation|October 15, 1995
Lipoprotein(a) may have contrasting effects on different aspects of atherosclerotic coronary diseaseR Narang, S Niththyananthan, C Nonis, et al.
Archives of Physical Medicine and Rehabilitation|May 1, 1974
Arthrography in the diagnosis of shoulder pain and immobilityJ J Weiss, G R Thompson, V Doust, et al.
Lancet (London, England)|November 4, 1989
Plasma mevalonate response in lovastatin-related myopathyV M Maher, A Pappu, D R Illingworth, et al.
Clinical Rheumatology|December 1, 1982
X-linked spondyloepiphyseal dysplasia tarda: mucopolysaccharide excretion studiesG R Thompson, D E Thompson, D S McCann, et al.
Archives of Internal Medicine|November 1, 1978
Familial occurrence of hyperuricemia, gout, and medullary cystic diseaseG R Thompson, J J Weiss, R T Goldman, et al.
Atherosclerosis|November 1, 1995
Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity?V M Maher, J J Gallagher, G R Thompson, et al.
Michigan Medicine|September 1, 1970
A controlled study of niacinamide therapyG R Thompson, I F Duff, E F Hvidberg, et al.
Pageof 26